Literature DB >> 19904830

Excision of reprogramming transgenes improves the differentiation potential of iPS cells generated with a single excisable vector.

Cesar A Sommer1, Andreia Gianotti Sommer, Tyler A Longmire, Constantina Christodoulou, Dolly D Thomas, Monica Gostissa, Fred W Alt, George J Murphy, Darrell N Kotton, Gustavo Mostoslavsky.   

Abstract

The residual presence of integrated transgenes following the derivation of induced pluripotent stem (iPS) cells is highly undesirable. Here we demonstrate efficient derivation of iPS cells free of exogenous reprogramming transgenes using an excisable polycistronic lentiviral vector. A novel version of this vector containing a reporter fluorochrome allows direct visualization of vector excision in living iPS cells in real time. We find that removal of the reprogramming vector markedly improves the developmental potential of iPS cells and significantly augments their capacity to undergo directed differentiation in vitro. We further propose that methods to efficiently excise reprogramming transgenes with minimal culture passaging, such as those demonstrated here, are critical since we find that iPS cells may acquire chromosomal abnormalities, such as trisomy of chromosome 8, similar to embryonic stem cells after expansion in culture. Our findings illustrate an efficient method for the generation of transgene-free iPS cells and emphasize the potential beneficial effects that may result from elimination of integrated reprogramming factors. In addition, our results underscore the consequences of long-term culture that will need to be taken into account for the clinical application of iPS cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19904830      PMCID: PMC4848036          DOI: 10.1002/stem.255

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  35 in total

1.  Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution.

Authors:  Nimet Maherali; Rupa Sridharan; Wei Xie; Jochen Utikal; Sarah Eminli; Katrin Arnold; Matthias Stadtfeld; Robin Yachechko; Jason Tchieu; Rudolf Jaenisch; Kathrin Plath; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2007-06-07       Impact factor: 24.633

2.  Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer.

Authors:  Gustavo Mostoslavsky; Attila J Fabian; Sean Rooney; Frederick W Alt; Richard C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-24       Impact factor: 11.205

3.  Induced pluripotent stem cells generated without viral integration.

Authors:  Matthias Stadtfeld; Masaki Nagaya; Jochen Utikal; Gordon Weir; Konrad Hochedlinger
Journal:  Science       Date:  2008-09-25       Impact factor: 47.728

4.  Generation of mouse induced pluripotent stem cells without viral vectors.

Authors:  Keisuke Okita; Masato Nakagawa; Hong Hyenjong; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Science       Date:  2008-10-09       Impact factor: 47.728

5.  Generation of germline-competent induced pluripotent stem cells.

Authors:  Keisuke Okita; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

6.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.

Authors:  Marius Wernig; Alexander Meissner; Ruth Foreman; Tobias Brambrink; Manching Ku; Konrad Hochedlinger; Bradley E Bernstein; Rudolf Jaenisch
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

7.  Wnt, activin, and BMP signaling regulate distinct stages in the developmental pathway from embryonic stem cells to blood.

Authors:  M Cristina Nostro; Xin Cheng; Gordon M Keller; Paul Gadue
Journal:  Cell Stem Cell       Date:  2008-01-10       Impact factor: 24.633

8.  Role of the murine reprogramming factors in the induction of pluripotency.

Authors:  Rupa Sridharan; Jason Tchieu; Mike J Mason; Robin Yachechko; Edward Kuoy; Steve Horvath; Qing Zhou; Kathrin Plath
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

9.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.

Authors:  Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Keisuke Okita; Yuji Mochiduki; Nanako Takizawa; Shinya Yamanaka
Journal:  Nat Biotechnol       Date:  2007-11-30       Impact factor: 54.908

10.  piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells.

Authors:  Knut Woltjen; Iacovos P Michael; Paria Mohseni; Ridham Desai; Maria Mileikovsky; Riikka Hämäläinen; Rebecca Cowling; Wei Wang; Pentao Liu; Marina Gertsenstein; Keisuke Kaji; Hoon-Ki Sung; Andras Nagy
Journal:  Nature       Date:  2009-03-01       Impact factor: 49.962

View more
  126 in total

Review 1.  Induced pluripotent stem cells--opportunities for disease modelling and drug discovery.

Authors:  Marica Grskovic; Ashkan Javaherian; Berta Strulovici; George Q Daley
Journal:  Nat Rev Drug Discov       Date:  2011-11-11       Impact factor: 84.694

Review 2.  Smooth muscle and other cell sources for human blood vessel engineering.

Authors:  Sumati Sundaram; Laura E Niklason
Journal:  Cells Tissues Organs       Date:  2011-10-25       Impact factor: 2.481

3.  Non-viral iPSCs: a safe way for therapy?

Authors:  Weiqi Zhang; Di Guan; Jing Qu; Weizhou Zhang; Guang-Hui Liu
Journal:  Protein Cell       Date:  2012-04       Impact factor: 14.870

4.  Methods of cell purification: a critical juncture for laboratory research and translational science.

Authors:  Peter J Amos; Esra Cagavi Bozkulak; Yibing Qyang
Journal:  Cells Tissues Organs       Date:  2011-10-12       Impact factor: 2.481

5.  Protein transduction from retroviral Gag precursors.

Authors:  Christine Voelkel; Melanie Galla; Tobias Maetzig; Eva Warlich; Johannes Kuehle; Daniela Zychlinski; Juergen Bode; Tobias Cantz; Axel Schambach; Christopher Baum
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

Review 6.  Induced pluripotency: history, mechanisms, and applications.

Authors:  Matthias Stadtfeld; Konrad Hochedlinger
Journal:  Genes Dev       Date:  2010-10-15       Impact factor: 11.361

7.  Rhesus Macaque iPSC Generation and Maintenance.

Authors:  Ravi Chandra Yada; So Gun Hong; Yongshun Lin; Thomas Winkler; Cynthia E Dunbar
Journal:  Curr Protoc Stem Cell Biol       Date:  2017-05-16

8.  Derivation and characterization of a transgene-free human induced pluripotent stem cell line and conversion into defined clinical-grade conditions.

Authors:  Jason P Awe; Agustin Vega-Crespo; James A Byrne
Journal:  J Vis Exp       Date:  2014-11-26       Impact factor: 1.355

9.  Enhancer priming by H3K4 methyltransferase MLL4 controls cell fate transition.

Authors:  Chaochen Wang; Ji-Eun Lee; Binbin Lai; Todd S Macfarlan; Shiliyang Xu; Lenan Zhuang; Chengyu Liu; Weiqun Peng; Kai Ge
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-03       Impact factor: 11.205

10.  Induced pluripotent stem cell reprogramming by integration-free Sendai virus vectors from peripheral blood of patients with craniometaphyseal dysplasia.

Authors:  I-Ping Chen; Keiichi Fukuda; Noemi Fusaki; Akihiro Iida; Mamoru Hasegawa; Alexander Lichtler; Ernst J Reichenberger
Journal:  Cell Reprogram       Date:  2013-11-12       Impact factor: 1.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.